Free Trial

Lakeshore Biopharma (LSB) News Today

Lakeshore Biopharma logo
$3.70 +0.09 (+2.49%)
As of 01/3/2025 05:39 PM Eastern
LakeShore Biopharma’s Financial Leap and Rabies Vaccine Trial Approval
LakeShore Biopharma Co Ltd Ordinary Shares
LakeShore Biopharma Advances PIKA Rabies Vaccine Approval
LakeShore Biopharma Announces Leadership Transition
LakeShore Biopharma Achieves Nasdaq Compliance Milestone
LakeShore Biopharma Advances with Rabies Vaccine Trial
LakeShore Biopharma Co., Ltd (H6Z.F)
LakeShore Biopharma Announces Leadership Transitions
LakeShore Biopharma Co., Ltd (LSB)
LakeShore Biopharma Co., Ltd (LSBPW)
LakeShore Biopharma Co Ltd (LSB)
LakeShore Biopharma Co. Ltd. Wt
Get Lakeshore Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LSB and its competitors with MarketBeat's FREE daily newsletter.


LSB Media Mentions By Week

LSB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LSB
News Sentiment

0.00

0.87

Average
Medical
News Sentiment

LSB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LSB Articles
This Week

0

1

LSB Articles
Average Week

Get Lakeshore Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LSB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LSB) was last updated on 1/5/2025 by MarketBeat.com Staff
From Our Partners